# Granisetron

## Grantron inj 3mg/3mL

| TAH Drug Code      | [IGRA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IGRA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention or treatment of nausea & vomiting induced by cytostatic therapy & radiation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | Prophylaxis or treatment of chemotherapy-induced nausea and vomiting: Prophylactic dose given before chemotherapy. Adult: 1-3 mg (10-40 mcg/kg) either as IV bolus over not less than 30 seconds or diluted in 20-50 mL infusion fluid and administered over >5 minutes. Maximum dose over 24 hours: 9 mg. Children: 10-40 mcg/kg body weight (up to 3 mg) diluted in 10-30 mL infusion fluid and administered over >5 minutes. One additional dose may be given within 24 hr if necessary. (Repeat infusions should be separated with each by at least 10-minute intervals.) Prevention & treatment of radiation-induced nausea and vomiting: Prophylactic dose given before radiation. Adult: 1-3 mg (10-40 mcg/kg) either as IV bolus over not less than 30 seconds or diluted in 20-50 mL infusion fluid and administered over >5 minutes. Maximum: 9 mg/24 hours. Postoperative nausea and vomiting: Adult: 1 mg (10 mcg/kg) either as IV bolus over not less than 30 seconds. Maximum: 3 mg/24 hours. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity to granisetron or related substances.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Common: Asthenia (oral, 14-18%), Headache (8.6-21%), Somnolence (up to 10%), Fever (3-56%), Hypertension, Hypotension, Dermatitis, Flushing, Rash, Constipation, Diarrhea, Disorder of taste, Indigestion, Xerostomia, Increased liver enzymes, Central nervous system stimulation, Dizziness, Extrapyramidal sign, Insomnia, Agitation, Anxiety, Oliguria, Copious sputum, Cough, Pain. Serious: Prolonged QT interval, Bradyarrhythmia, Cardiac dysrhythmia, Electrocardiogram abnormal, Hypersensitivity reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/granisetron-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

## Setron 2mg

| TAH Drug Code      | [OSET](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSET)                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention or treatment of chemotherapy or radiation therapy associated nausea and vomiting.                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Prophylaxis of Chemotherapy-induced nausea and vomiting: 2 mg QD, taking 1 hour before chemotherapy at the first time. Prophylaxis of Radiation therapy-induced nausea and vomiting: 2 mg QD, taking 1 hour before radiation therapy at the first time. Not up to a week.                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Hypersensitivity to granisetron or any of its components.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Common: Asthenia (oral, 14-18%), Headache (8.6-21%), Somnolence (up to 10%), Fever (3-56%), Hypertension, Hypotension, Dermatitis, Flushing, Rash, Constipation, Diarrhea, Disorder of taste, Indigestion, Xerostomia, Increased liver enzymes, Central nervous system stimulation, Dizziness, Extrapyramidal sign, Insomnia, Agitation, Anxiety, Oliguria, Copious sputum, Cough, Pain. Serious: Prolonged QT interval, Bradyarrhythmia, Cardiac dysrhythmia, Electrocardiogram abnormal, Hypersensitivity reaction. |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/granisetron-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                            |

